Our study showed that, in the DN model group, the podocyte markers, nephrin and podocin, were down-regulated, while mesenchymal markers, α-SMA and FSP-1, were up-regulated; however, the changes in these markers were reversed following treatment with BSHX decoction. This evidence concerns the gene S100A4 and liver dysplastic nodule.